AbbVie Inc.(ABBV) Q3
EPS: 3.82 USD; Forecast 3.73 USD
Revenue: 17.4B USD; Forecast 17.32B USD
Reporting period: 2026 Q3 (period ended 2026-09-30)
Release date: 2026-10-30